EUVIMEDEUVIMED entdecken
Crossref

Chemotherapy-induced peripheral neuropathy: neurophysiological mechanisms, emerging biomarkers, and evidence-based prevention strategies

Hossam R. Alkashgari

Oncology in Clinical Practice · 15.01.2026 · 22

DOI: 10.5603/ocp.113058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology in Clinical Practice, online erschienen am 15.01.2026. Verfasst von Hossam R. Alkashgari.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Alkashgari, H. R. (2026). Chemotherapy-induced peripheral neuropathy: neurophysiological mechanisms, emerging biomarkers, and evidence-based prevention strategies. Oncology in Clinical Practice, 22(0). https://doi.org/10.5603/ocp.113058

Vancouver

Alkashgari HR. Chemotherapy-induced peripheral neuropathy: neurophysiological mechanisms, emerging biomarkers, and evidence-based prevention strategies. Oncology in Clinical Practice. 2026;22(0). doi:10.5603/ocp.113058

BibTeX
@article{Alkashgari2026,
  author = {Alkashgari, Hossam R.},
  title = {Chemotherapy-induced peripheral neuropathy: neurophysiological mechanisms, emerging biomarkers, and evidence-based prevention strategies},
  journal = {Oncology in Clinical Practice},
  year = {2026},
  volume = {22},
  number = {0},
  doi = {10.5603/ocp.113058}
}
Kostenlos starten →